Depression as a predictor of disease progression and mortality in cancer patients
Top Cited Papers
- 3 November 2009
- Vol. 115 (22), 5349-5361
- https://doi.org/10.1002/cncr.24561
Abstract
Cancer patients and oncologists believe that psychological variables influence the course of cancer, but the evidence remains inconclusive. This meta‐analysis assessed the extent to which depressive symptoms and major depressive disorder predict disease progression and mortality in cancer patients. Using the MEDLINE, PsycINFO, CINAHL, and EMBASE online databases, the authors identified prospective studies that examined the association between depressive symptoms or major/minor depression and risk of disease progression or mortality in cancer patients. Two raters independently extracted effect sizes using a random effects model. Based on 3 available studies, depressive symptoms were not shown to significantly predict cancer progression (risk ratio [RR] unadjusted = 1.23; 95% confidence interval [CI], 0.85‐1.77; P = .28). Based on data from 25 independent studies, mortality rates were up to 25% higher in patients experiencing depressive symptoms (RR unadjusted = 1.25; 95% CI, 1.12‐1.40; P < .001), and up to 39% higher in patients diagnosed with major or minor depression (RR unadjusted = 1.39; 95% CI, 1.10‐1.89; P = .03). In support of a causal interpretation of results, there was no evidence that adjusting for known clinical prognostic factors diminished the effect of depression on mortality in cancer patients. This meta‐analysis presented reasonable evidence that depression predicts mortality, but not progression, in cancer patients. The associated risk was statistically significant but relatively small. The effect of depression remains after adjustment for clinical prognosticators, suggesting that depression may play a causal role. Recommendations were made for future research to more clearly examine the effect of depression on cancer outcomes. Cancer 2009. © 2009 American Cancer Society.Keywords
This publication has 82 references indexed in Scilit:
- Psychosocial Factors and Survival of Young Women With Breast Cancer: A Population-Based Prospective Cohort StudyJournal of Clinical Oncology, 2008
- Pre‐transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantationPsycho‐Oncology, 2007
- Baseline psychosocial predictors of survival in localised breast cancerBritish Journal of Cancer, 2006
- Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohortEuropean Journal of Cancer, 2005
- Association Between Symptom Distress and Survival in Outpatients Seen in a Palliative Care Cancer CenterJournal of Pain and Symptom Management, 2005
- Psychological Distress and Cancer SurvivalPsychosomatic Medicine, 2003
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002
- A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancerPsycho‐Oncology, 1998
- Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium HospitalEuropean Journal of Cancer, 1997
- Psychological Predictors of Survival in Cancer Patients Undergoing Radiation TherapyPsychotherapy and Psychosomatics, 1987